SM
Sullivan Mark
Officier
OtherM
€752,260
▼ Sales (11 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Sullivan Mark, Officier. Insider active across 3 companies, notably Sesen Bio, Inc.. Aggregated, 17 reports have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €752k. Activity tracked since 18 February 2022. The latest transaction was disclosed on 12 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sullivan Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
62,500 shares0Common SharesSEC:0001193125-26-345837:0
13,008 sharesCommon SharesSEC:0001193125-26-285567:0
62,500 sharesCommon SharesSEC:0001193125-26-276879:0
10,702 shares@ US$18.47100.0% of flowCommon SharesSEC:0001193125-26-126827:0
125,000 shares0Common SharesSEC:0001193125-26-039579:0
11,276 shares@ US$13.146924.9% of flowCommon SharesSEC:0001193125-25-335481:0
11,278 shares@ US$9.7724.9% of flowCommon SharesSEC:0001193125-25-220848:0
11,491 shares@ US$6.8023.5% of flowCommon SharesSEC:0000950170-25-090431:0
6,576 shares@ US$6.7418.9% of flowCommon SharesSEC:0000950170-25-045394:0
150,000 shares0Common SharesSEC:0000950170-25-038798:0
4,519 shares@ US$7.4314.8% of flowCommon SharesSEC:0001104659-24-132160:0
4,430 shares@ US$5.9810.9% of flowCommon SharesSEC:0000950170-24-109447:0
17,854 shares@ US$7.2255.3% of flowCommon SharesSEC:0000950170-24-077497:0
200,000 shares0Common SharesSEC:0001209191-23-024335:0
100,978 shares@ US$0.58771.7% of flowCommon StockSEC:0001485003-23-000111:0
39,831 shares@ US$0.587328.3% of flowCommon StockSEC:0001485003-23-000066:0
339,525 shares0Common StockSEC:0001485003-22-000022:0
About Sullivan Mark
Sullivan Mark is an Officier associated with Mind Medicine (MindMed) Inc., Definium Therapeutics, Inc., and Sesen Bio, Inc., where he is Chief Legal Officer, Chief Legal Officer, and General Counsel & Secretary. Across 16 filings in total, the 16 sampled filings, from 2022-02-23 to 2026-06-26, are sale transactions totaling EUR 752260, including EUR 170186.4167376335 at Definium Therapeutics, Inc. and EUR 125786.8981395954, EUR 120364.5747956384, EUR 94476.8323022514, EUR 66878.2187585699 at Mind Medicine (MindMed) Inc., as well as EUR 55557.60340857484 at Sesen Bio, Inc.